[LGND] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 39.09%
YoY- 1,208.39%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 90,043 56,157 50,464 33,375 27,995 29,267 38,185 77.44%
PBT 95,579 55,312 30,665 12,071 8,300 6,193 7,230 461.74%
Tax 22,419 10,033 37,675 3,645 2,242 1,114 10,355 67.59%
NP 73,160 45,279 -7,010 8,426 6,058 5,079 -3,125 -
Tax Rate -23.46% -18.14% -122.86% -30.20% -27.01% -17.99% -143.22% -
Total Cost 16,883 10,878 57,474 24,949 21,937 24,188 41,310 -45.01%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 81.25 80.63 -13.89 25.25 21.64 17.35 -8.18 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS 3.45 2.13 -0.34 0.40 0.29 0.24 -0.15 -
EPS Diluted 2.99 1.83 -0.33 0.36 0.26 0.22 -0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.